iiinova — where your digital self keeps evolving

oae-evcna.bsky.social @oae-evcna.bsky.social · 29/09/2026

📢EVCNA invites submissions to our Special Topic: 🔬 Beyond Exosomes: Advances in #ExtracellularVesicle Research and Applications Explore advances in EV biology, heterogeneity, biomarkers, therapeutics, technologies, and translational applications. 📄https://www.oaepublish.com/specials/evcna.10630

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 29/09/2026

🔬🫀 From cardiac #EVs to #mitochondrial function Region-specific human cardiac EVs exhibit distinct proteomic and lipidomic profiles and differentially regulate mitochondrial respiration and #ATP production. 🔗 www.oaepublish.com/articles/evc... @labogden.bsky.social @chpreusser.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 28/09/2026

🌱 What can bacterial #EVs reveal about stress? #Bile exposure reshapes EV size and cargo in Lactiplantibacillus plantarum, highlighting bacterial EVs as dynamic stress responders. 🧫🧬 🔗 www.oaepublish.com/articles/evc...

111

oae-evcna.bsky.social @oae-evcna.bsky.social · 28/09/2026

🧬 Better data, robust biomarkers! 🔬 This Original Article introduces caRNAge, a user-friendly pipeline addressing bias and confounding in small RNA-Seq analysis—supporting reliable EV biomarker discovery and pathway analysis. 📊 🔗 www.oaepublish.com/articles/evc... @fhelmbacher.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 24/09/2026

🧬What drives tumor #drugresistance? This Review explores the multidimensional roles of #extracellularvesicles in drug resistance, covering resistance mechanisms, biomarkers, engineered EV-based drug delivery, and clinical translation. www.oaepublish.com/articles/evc... @princess-vimentin.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 24/09/2026

🚀What can microbial #extracellularvesicles offer to medicine? This Review highlights the advantages of #MEVs and synthetic biology-based engineering, with applications in drug delivery, immune modulation, #biomarkers, and #therapeutics. 💊 🔗 www.oaepublish.com/articles/evc... @erictopol.bsky.social

131

oae-evcna.bsky.social @oae-evcna.bsky.social · 23/09/2026

💊How do exosomes shape cancer multidrug resistance? This Review examines resistance-related cargo, tumor microenvironment interactions, and the potential of exosomes for resistance monitoring and reversal therapy.🔬 www.oaepublish.com/articles/evc... @goetzjacky.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 23/09/2026

🌿🧬Plant-derived nanoparticles for rheumatoid arthritis This Article explores engineered Tripterygium wilfordii-derived nanoparticles for targeted RA therapy. ✨ ROS scavenging 🧩 Macrophage reprogramming 🎯 Joint targeting 🦴 Cartilage protection 🔗 www.oaepublish.com/articles/evc... @maom.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 22/09/2026

📢Call for Papers | EVCNA Special Topic 🦴Extracellular Vesicles and Circulating Nucleic Acids in Musculoskeletal Diseases: From Molecular Mechanisms to Biomarkers and Translational Therapeutics 📅 Deadline: 30 June 2027 🌍 Share your latest discoveries! www.oaepublish.com/specials/evc...

010

oae-evcna.bsky.social @oae-evcna.bsky.social · 22/09/2026

✨ #Aptamers × #ExtracellularVesicles A new Review in EVCNA highlights how aptamer technologies are shaping EV capture, analysis, and engineering, with emerging opportunities in targeted delivery, liquid biopsy, and precision medicine. 💡 www.oaepublish.com/articles/evc... @nsrhighlights.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 21/09/2026

🧬 EVCNA Roundtable | Replay Available! Our roundtable on EVs and SECmeres has successfully concluded! 🎉 Thanks to Michael W. Pfaffl and Navneet Dogra for the insightful discussion. 🔬 🎥 Missed it? Watch the replay and join the discussion! www.oaepublish.com/webinars/evc...

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 21/09/2026

🧬From biogenesis to therapeutic implications! How might migrasomes influence the tumor #microenvironment and #cancer progression? This Review provides an updated overview of their roles in metastasis, drug resistance, diagnosis, and therapy. www.oaepublish.com/articles/evc... @goetzjacky.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 20/09/2026

🧬Calling researchers in #EVs & #cancer! EVCNA invites submissions to our Special Topic: Extracellular Vesicles in Cancer Diagnosis and Therapy: From Liquid Biopsy to Targeted Nanomedicine 🧪 📌Original Research | Reviews | Perspectives |Clinical Studies www.oaepublish.com/specials/evc...

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 20/09/2026

🌱 Beyond alkaloids and flavonoids, could #nucleicacids be new bioactive components of medicinal plants? This Review examines plant-derived RNAs, their #pharmacological functions, mechanisms, and pharmaceutical potential. 🧬💊 🔗 www.oaepublish.com/articles/evc... @nsrhighlights.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 18/09/2026

Special Topic | Call for Papers #ExtracellularVesicle-Mediated Communication in the Gut–Liver–Brain Axis 👤 Guest Editor: Dr. Vicente Felipo Researchers worldwide are invited to submit work on EV communication, neuroinflammation, microbiota, & more! 🔗https://www.oaepublish.com/specials/evcna.10613

010

oae-evcna.bsky.social @oae-evcna.bsky.social · 18/09/2026

🌿 From herbal decoction to vesicle-like nanoparticles! Nanoparticles derived from Pueraria lobata decoction alleviate colitis through gut microbiota modulation, while improving intestinal inflammation and barrier function. 🦠🔬 📖 Read more: www.oaepublish.com/articles/evc... @fhelmbacher.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 17/09/2026

🚀 Starting soon! Join EVCNA’s roundtable, “Extracellular Vesicles and SECmeres: Different Packages Carrying Different Messages.” Discover new perspectives on EVPs, SECmeres, and liquid biopsy with Michael W. Pfaffl and Navneet Dogra. 🧬 www.oaepublish.com/webinars/evc...

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 17/09/2026

🧠 How can #stemcell-derived #extracellularvesicles advance therapies for #neuropsychiatric disorders? This Review explores their neuroprotective mechanisms, therapeutic potential, and key challenges in clinical translation. 🔬 www.oaepublish.com/articles/evc... @drwp.bsky.social @jdevos.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 16/09/2026

🧬Coming up soon! Join EVCNA’s roundtable on 17 September! 🎙️Michael W. Pfaffl & Navneet Dogra ⏰10:00–11:00 AM EDT | 16:00–17:00 CEST | 22:00–23:00 CST Discover how #extracellularvesicles and SECmeres carry different messages and may advance biomarkers, therapy and liquid biopsy

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 16/09/2026

🧬 Engineering Bacterial #OMVs Through Hypervesiculation 🦠 More β-barrel #OMPs, more OMVs! Explore how protein overproduction induces hypervesiculation in E. coli BL21(DE3), offering a platform for recombinant OMP-enriched vesicles. 📚 www.oaepublish.com/articles/evc... @fhelmbacher.bsky.social

010

oae-evcna.bsky.social @oae-evcna.bsky.social · 15/09/2026

📢Don’t miss this roundtable! #ExtracellularVesicles and SECmeres: Different Packages Carrying Different Messages 📅17 September 2026 🎙️Michael W. Pfaffl & Navneet Dogra Join the discussion, share insights, and connect with scholars worldwide! Register: www.oaepublish.com/webinars/evc...

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 15/09/2026

👁️💧 What is the future of extracellular vesicle therapy for #dryeyedisease? This Review discusses the principles, progress, therapeutic strategies, and challenges of #MSC-derived #EVs in ocular surface treatment. 🔗 www.oaepublish.com/articles/evc... @profswatson.bsky.social @arvoinfo.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 14/09/2026

🧬 Join EVCNA’s Roundtable on Sept 17! Explore how extracellular vesicles and SECmeres carry distinct messages and their potential in therapy and liquid biopsy. 🎙️ Speaker: Dr. Navneet Dogra 🎤 Moderator: Prof. Michael W. Pfaffl 📅 Register: www.oaepublish.com/webinars/evc...

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 14/09/2026

🔬 How does mechanical stress drive drug resistance in solid tumors? This review explores the “mechanical stress–cytoskeleton–exosomes–autophagy” axis, revealing how physical cues may propagate resistant phenotypes across tumor regions. 🧬Read: www.oaepublish.com/articles/evc... @rna-ken.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 11/09/2026

📢 New Special Topic in EVCNA! 🧬 Extracellular Vesicle-Mediated Communication in the #Gut–Liver–Brain Axis Explore how #EVs regulate peripheral inflammation, neuroinflammation, and neurological dysfunction. 👤 Guest Editor: Dr. Vicente Felipo www.oaepublish.com/specials/evc...

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 11/09/2026

🔬 Oral bacterial-derived #EVs carry virulence factors, nucleic acids, and metabolites that may shape host-cell functions and inflammatory pathways. This Review summarizes their potential roles in oral and systemic diseases. 🦷🧬 🔗 Read: www.oaepublish.com/articles/evc... @maom.bsky.social

111

oae-evcna.bsky.social @oae-evcna.bsky.social · 10/09/2026

🧬How do #EVs shape the tumor microenvironment? This study highlights exosomal LYPLAL1-DT as a mediator of bidirectional communication between small cell #lungcancer and endothelial cells, promoting tumor progression and angiogenesis. 🧬 www.oaepublish.com/articles/evc... @goetzjacky.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 10/09/2026

🧬 From liquid biopsy to biomarker signatures! This EVCNA Review highlights how rigorous EV-miRNA quantification, standardized workflows, and robust normalization can improve reproducibility and accelerate clinical translation. 🔬🩸 Explore: www.oaepublish.com/articles/evc... @labogden.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 09/09/2026

🚀 What messages do #extracellularvesicles carry? Join the EVCNA Roundtable on Sep 17 to explore EVPs, SECmeres, brain-specific RNA markers & liquid biopsy with Dr. Navneet Dogra, moderated by Prof. Michael W. Pfaffl! 🔬 📅 Sep 17 🧬 👉 Register now! www.oaepublish.com/webinars/evc...

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 09/09/2026

✨ Turning stem cells into stronger EV producers! New EVCNA research shows that DFO-primed #stemcell-derived #sEVs enhance angiogenesis, support vascularized tissue integration, and promote reparative macrophage polarization. 🧬🩸 👇 www.oaepublish.com/articles/evc... @fhelmbacher.bsky.social

010

oae-evcna.bsky.social @oae-evcna.bsky.social · 08/09/2026

🚨Can extracellular vesicles create an immunosuppressive niche in liver #cancer? 🧬 NID1-enriched #EVs promote mregDC differentiation → Treg infiltration → HCC progression, uncovering a new EV-driven mechanism in the tumor microenvironment. www.oaepublish.com/articles/evc... @goetzjacky.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 08/09/2026

🧠“#Extracellularvesicle therapeutics in Alzheimer’s disease: mechanisms, progress, and prospects” Exploring EV-based therapies for #Alzheimer’s disease, from mechanisms and emerging strategies to translational challenges and future directions. www.oaepublish.com/articles/evc... @labogden.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 07/09/2026

🚀How can EVs make chemotherapy more targeted? This Article develops tumor-targeted multifunctional #EVs loaded with cisplatin and transferrin ligands, enabling selective killing of lung cancer cells while reducing toxicity to normal cells. www.oaepublish.com/articles/evc... @ewingt-phd.bsky.social

010

oae-evcna.bsky.social @oae-evcna.bsky.social · 07/09/2026

🌹 From roses to brighter skin! A new Original Article reveals that rose-derived extracellular vesicle-like particles (RS-EVLP) can inhibit melanogenesis by suppressing the key MITF–TYR/TRP pathway. 🧬 Cell → 🐟 Zebrafish → 👩‍🔬 Clinical study 🔗 www.oaepublish.com/articles/evc... @maom.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 04/09/2026

🌿 EVCNA Expert Interview Series XVII Prof. Dr. Gabriella Pocsfalvi shares insights on Ginkgo biloba-derived nanovesicles, #plantderivedEV research, emerging directions, and advice for young researchers. 🎥 Watch the interview! 🔗 www.oaepublish.com/interviews/e...

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 04/09/2026

🔬Featured in EVCNA Human UCMSC-derived nanovesicles ameliorate acute lung injury by delivering hsa-let-7g-5p and suppressing the NF-κB/NLRP3 pathway, offering insights into potential cell-free therapies for inflammatory #lungdiseases. 🔗 www.oaepublish.com/articles/evc... @dianvanderwaldr.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 03/09/2026

🎉 Welcome Dr. Alexis Stamatikos to the EVCNA Junior Editorial Board! 🔬 At Clemson University, he studies atherosclerosis, vascular inflammation, cholesterol regulation, and atheroprotective nanotherapies. We’re excited to have his expertise on board! www.oaepublish.com/evcna/junior...

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 03/09/2026

🔬 New Original Article from the University of Pennsylvania! Proteomic profiling of MEG-01-derived EV subtypes reveals distinct #lEV and #sEV signatures, shedding light on #EV heterogeneity and myeloproliferative neoplasm biology. 🧬 Read more 👇 www.oaepublish.com/articles/evc... @maom.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 02/09/2026

🦠➡️🧬➡️🧠From parasite infection to neural signaling! A new Original Article explores how Toxoplasma gondii infection reshapes EV miRNAs, revealing potential molecular links to neuroplasticity, neurotransmission and neuroinflammation. 🔗 www.oaepublish.com/articles/evc... @labogden.bsky.social

132

oae-evcna.bsky.social @oae-evcna.bsky.social · 02/09/2026

🌿 From Ginkgo biloba to the future of EV research! In EVCNA Expert Interview Series XVII, Prof. Gabriella Pocsfalvi shares insights into plant-derived nanovesicles, research challenges, future opportunities, and advice for young EV researchers. 🔬🎙️ @allcell9.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 01/09/2026

✨Missed our latest roundtable? Now’s your chance to catch up! Explore key insights on next-generation EV detection technologies, from advanced nanoplatforms to clinical applications, with leading experts. 🧬🔬 👉Watch the replay and join the conversation! www.oaepublish.com/webinars/evc...

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 01/09/2026

🧬How can engineered EVs overcome therapeutic barriers? A new Review explores EV engineering for cargo loading, targeting, and intracellular delivery, highlighting challenges in immunogenicity, manufacturing, and translation. 🔗https://www.oaepublish.com/articles/evcna.2026.85 @chpreusser.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 31/08/2026

Different packages, different messages! Join the upcoming EVCNA Roundtable exploring extracellular vesicles and SECMeres with Dr. Navneet Dogra, moderated by Prof. Michael W. Pfaffl. 📅 Sep 17, 2026 ⏰ 10 AM EDT | 4 PM CEST 🚀 Don’t miss it! oaepublish.com/webinars/evc...

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 31/08/2026

🚀 Advancing EV profiling! A study from the International University of Health and Welfare uses SPRi to profile circulating EVs in type 2 diabetes and hypertension. 🧬 Distinct EV signatures separate disease groups from healthy controls. 📖 www.oaepublish.com/articles/evc... @fhelmbacher.bsky.social

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 28/08/2026

🚀 Advancing #EV-based #cancertherapy! We’re delighted to welcome María Sancho Albero from the University of Zaragoza to the EVCNA Junior Editorial Board! 🧬 Her research bridges extracellular vesicles, nanomaterials, targeted delivery and cancer therapy. 🔬🎯

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 28/08/2026

🧠🔬How does #HIV Nef reach the extracellular space? A article from the University of Ljubljana shows that Nef expression in human microglia drives the release of distinct Nef-containing #extracellularvesicles, offering new insights into HAND. www.oaepublish.com/articles/evc... @sciam.bsky.social

010

oae-evcna.bsky.social @oae-evcna.bsky.social · 27/08/2026

🎉 Welcome Prof. Malgorzata Czystowska-Kuzmicz to the EVCNA Junior Editorial Board! 🔬 Associate Professor at the Medical University of Warsaw, her research focuses on EV biomarkers, cancer & inflammatory immunomodulation, regenerative medicine, and stem cell-derived #EVs.🧬✨✨

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 27/08/2026

🌟 #EVs meet #boneaging! A Review from Shanghai University explores EV-based strategies for age-related bone disorders, covering mammalian, bacterial, plant- and organoid-derived EVs and their potential for bone regeneration. 🦴🧬 📖Read more: www.oaepublish.com/articles/evc... @nnz79.bsky.social

110

oae-evcna.bsky.social @oae-evcna.bsky.social · 26/08/2026

🌟 Welcome, Prof. Naveed Akbar! We’re delighted to welcome Prof. Akbar from the University of Oxford to the EVCNA Junior Editorial Board! 🎉 His research explores extracellular vesicles in cardiovascular & metabolic diseases. 🫀🧬 Welcome aboard! 🚀

000

oae-evcna.bsky.social @oae-evcna.bsky.social · 26/08/2026

🚀 Exploring the crossroads of EVs and autophagy! From selective cargo loading to degradation and secretion, extracellular vesicle pathways involve a complex network of shared molecular machinery.🧬 🔗 Read the review: www.oaepublish.com/articles/evc... @fhelmbacher.bsky.social @fhelmbacher.bsky.social

000